metastasized castration-resistant prostate cancer

You have access
Repeated ¹⁷⁷Lu-Labeled PSMA-617 Radioligand Therapy Using Treatment Activities of Up to 9.3 GBq
Hendrik Rathke, Frederik L. Giesel, Paul Flechsig, Klaus Kopka, Walter Mier, Markus Hohenfellner, Uwe Haberkorn and Clemens Kratochwil

Journal of Nuclear Medicine March 1, 2018, 59 (3) 459-465; DOI: https://doi.org/10.2967/jnumed.117.194209